| Regarding 'HPV Vaccination for Cervical Cancer Prevention is not Cost-effective in Japan' |
|
Arakawa, Ichiro
(Unit of Health Economics, Faculty of Pharmaceutical Science, Teikyo Heisei University)
Murasawa, Hideki (Unit of Health Economics, Faculty of Pharmaceutical Science, Teikyo Heisei University) Konno, Ryo (Department of Obstetrics and Gynecology, Saitama Medical Center, Jichi Medical University) |
| 1 | Boardman AE, Greenberg DH, VoningAR, et al (2011). Cost-Benefit Analysis Concept and Practice 4Th Edition Upper Saddle River. NJ, 408-13. |
| 2 | Drummond M, Sculpher MJ, Torrance GW, et al. (2005). Methods for Economic Evaluation of Health Care 3Rd Edition Oxford Press, NY, 31-34. |
| 3 | Drummond M, Jefferson TO (1996). Guideline for the authors and peer reviewers of economic submissions to the BMJ. BMJ, 313, 275-83. DOI |
| 4 | Hamashima C, Aoki D, Miyagi E, et al (2010). The Japanese guidance for cervical cancer screening. Jpn J Cin Oncol, 40, 485-502. DOI ScienceOn |
| 5 | Isshiki T (2014). HPV vaccination for cervical cancer prevention is not cost-effective in Japan. Asian Pac J Can Prev, 15, 6177-80. DOI |
| 6 | Konno R, Sasagawa T, Fukuda T, et al (2010). Cost-effectiveness analysis of prophylactic cervical cancer vaccination in Japanese women. Int J Gynecol Can, 20, 385-92. DOI |
| 7 | OECD (2011). OECD health data. |
| 8 | Uchida A, Tango M, Hosokawa K, et al (2010). Cost-Benefit Analysis: Cervical Cancer Vaccination. [online]http://www.pp.u-tokyo.ac.jp/courses/2010/documents/ |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
